undamentalytics Newsletter
Sign in

Medline Inc. revenue

Medline Inc.'s revenue was $28.43bn in fiscal 2025, up 11.5% on the year before. Since fiscal 2022 ($21.45bn) it has grown at a compound 9.9% a year.

Revenue history

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue21.423.225.528.4
Growth on the year before—+8.3%+9.8%+11.5%
Gross profit5.25.97.07.5
Gross margin24.3%25.3%27.3%26.4%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
United States $26.5B 93.1% ▲ 11.5%
Outside the US $2B 6.9% ▲ 11.0%

From Medline Inc.'s 10-K filed February 25, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Distributors: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Medline Inc. $27.43bn — —
Henry Schein $13.60bn 6.5% 2.6%
Cencora $332.77bn 5.1% 9.4%
McKesson $410.98bn 8.8% 13.1%
111, Inc. $1.75bn -12.7% —
Cosmos Health Inc. $73.7m 33.8% 14.8%

Compare with peers

Head to head: HSIC vs MDLNCOR vs MDLNMCK vs MDLN

More: Health Care Distributors stocks compared, Health Care sector, rankings of US companies

Figures from Medline Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Medline Inc.